CELL INTELLIGENCE · 肿瘤细胞治疗研究

CD18 靶向肽-药物偶联物通过选择性清除 M2 巨噬细胞重塑前列腺癌的免疫抑制肿瘤微环境

CD18-targeted peptide-drug conjugate remodels the immunosuppressive tumor microenvironment of prostate cancer by selective depletion of M2 macrophages

羧酸酯酶 2 工程化干细胞疗法在去势抵抗性前列腺癌中疗效优于胞嘧啶脱氨酶

Carboxylesterase 2-Engineered Stem Cell Therapy Shows Superior Efficacy over Cytosine Deaminase in Castration-Resistant Prostate Cancer.

实体瘤树突状细胞免疫治疗：转化研究与临床应用进展

Dendritic Cell Immunotherapy for Solid Tumors: Advances in Translational Research and Clinical Application.

前列腺癌在微生物交叉路口：照亮精准医学的新前沿

Prostate Cancer at the Microbial Crossroads: Illuminating a New Frontier in Precision Medicine.

前列腺癌免疫治疗：从“冷”肿瘤到“热”前景

Immunotherapy in Prostate Cancer: From a "Cold" Tumor to a "Hot" Prospect.

人肝内窦状γ/δ T 细胞的细胞毒性依赖于磷酸抗原和 NK 受体信号传导

Cytotoxicity of Human Hepatic Intrasinusoidal Gamma/Delta T Cells Depends on Phospho-antigen and NK Receptor Signaling.

肿瘤细胞中磷酸抗原的表达水平决定了 HI γδ T 细胞的细胞毒性，尽管 NK 激活受体、死亡配体和免疫检查点分子也对其细胞毒性有所贡献。γδ T 细胞是癌症免疫细胞治疗的有吸引力的候选者。